Live Trading News
Shayne Heffernan

Cathie Wood's Potential 2024 Stock Winners $GH $BEAM $DNA $NTLA

By Shayne Heffernan2 min read

In 2023, Cathie Wood showcased remarkable prowess with her Ark Innovation ETF (NYSEMKT: ARKK) witnessing a 67% surge, while the Ark Next Generation Internet ETF (NYSEMKT: ARKW) outpaced with a stellar 97% rise.

Now, as projections unfold for 2024, analysts anticipate significant growth potential for some stocks within Wood's portfolio, as depicted in the table below:

Stock Name

Ticker Symbol

2023 Performance

Average 12-Month Price Target

Expected Upside

Guardant Health

GH

Slightly Down

83%

High

Beam Therapeutics

BEAM

-30%

85%

Moderate

Ginkgo Bioworks

DNA

No Change

120%

High

Intellia Therapeutics

NTLA

-13%

168%

Very High

  1. Guardant Health: Despite its 2023 performance, analysts foresee an 83% rise, with unanimous buy or strong buy ratings.

  2. Beam Therapeutics: A 30% dip in 2023 hasn't deterred optimism, with an 85% potential upside despite some analyst downgrades.

  3. Ginkgo Bioworks: Stable performance in 2023, but projections suggest a 120% increase, though opinions on the stock are divided.

  4. Intellia Therapeutics: Despite a 13% drop last year, an impressive 168% potential upside is predicted, highlighting its significant potential.

Conclusion: While Wall Street's projections are ambitious, it's essential to approach these forecasts with caution. The lackluster 2023 performances of these stocks amidst a soaring market is a reminder that unforeseen macroeconomic factors can influence outcomes. However, Cathie Wood's long-term vision for these companies, considering their revolutionary technologies in early cancer detection, DNA modification, cell engineering, and gene editing, could be the real value proposition. Time will tell if Wall Street's 2024 predictions align with Wood's long-term strategy.

Shayne Heffernan

Keep reading
KXCO

What KXCO Is, and Why the Hard Problem Was Never Intelligence

The prevailing enthusiasm assumes the hard problem is intelligence. It is not. It is that banks, hospitals, courts and governments are being asked to let software act on their behalf with no way to establish who decided, on what basis, or whether the record will still read in a decade. KXCO founder Shayne Heffernan sets out the architecture that answers those questions, drawn as a graph, and argues that properly constructed AI is an amplifier of human judgement rather than a replacement for it.

Shayne Heffernan22 min
AI accountability

AI Intelligence Scales. Accountability Does Not. Why KXCO Is Built for It.

Capability is becoming abundant and everything abundant gets cheap. What does not get cheap is the person who has to sign, and they can only carry what they can see. Four conditions follow from that, and four independent authorities reached the first of them last month without knowing it.

Shayne Heffernan5 min
AI slop

AI is the Neat Handwriting of the Illiterate

A model in the hands of someone who has read the filing and walked the plant is a clerk. The same model, speaking for someone who has done neither, is a disguise. On AI slop, phantom citations and factslop, why finish stopped being evidence of work, and the containment layer KXCO built so a machine cannot speak as the institution until a source is attached.

Shayne Heffernan19 min
worthship

Worthship: Do Not Conform to the Age

Worthship is the older English word for worship, and it means to ascribe worth. Bishop Robert Barron preached Romans 12 on 30 August. This essay follows the text into the prison letters, and puts two questions to a graph: do the four readings of that Sunday agree, and was Paul free or in chains when he wrote about despair?

Shayne Heffernan17 min
Read Live Trading News on Telegram

Every story, signed and delivered.

Subscribe to the kxco channel and get the headline, the AI-written key takeaways, and the chain-anchor link the moment we publish. Audio versions and per-ticker subscriptions arrive in the next iteration.

Open @KnightsbridgeInsightsNo email required.